Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina

Table 1 Study population baseline characteristics, n (%)

	Adults (n = 21)	Pediatric (n = 24)
Age (years)
mean (SD)	42.9 (17.6)	9.7 (4.6)
Range (minimum-maximum)	19-75	3-17
Sex
Female	11 (52.4)	5 (20.8)
Male	10 (47.6)	19 (79.2)
Weight and BMI
Weight (kg), mean (SD)	57.5 (12.8)	27.3 (12.7)
BMI, mean (SD)	21.9 (3.4)	16.4 (1.9)
Time of parenteral support (years), mean (SD)	7 (5.9)	7.8 (4.7)
Cause of major intestinal resection
Vascular disease	9 (42.9)	0 (0)
Postoperative complication	5 (23.8)	0 (0)
Volvulus	3 (14.3)	8 (33.3)
Intestinal atresia	2 (9.5)	7 (29.2)
Gastroschisis	0 (0)	5 (20.8)
Injury/traumatic	2 (9.5)	1 (5.6)
Necrotizing enterocolitis	0 (0)	1 (4.2)
Other cause	0 (0)	2 (8.4)
Anatomy type
Type 1	2 (9.5)	1 (4.2)
Type 2	13 (61.9)	16 (66.7)
Type 3	6 (28.9)	7 (29.2)
Colon in continuity
Yes	19 (90.5)	22 (91.7)
No	2 (9.5)	2 (8.3)
Remanent colon
> 0%-25%	2 (9.5)	2 (8.3)
> 25%-50%	13 (61.9)	6 (25)
> 50%-75%	0 (0)	6 (25)
> 75%-100%	6 (28.6)	9 (37.5)
Other or not available	0 (0)	1 (4.2)
Remanent small bowel length (cm), mean (SD)	48.2 (40.6)	43 (39.8)
Ostomy
Colostomy	0 (0)	2 (8.3)
Jejunostomy	1 (4.8)	1 (4.2)
Ileostomy	1 (4.8)	0 (0)

BMI: Body mass index.